(Q40577628)

21 September 2017

title

Inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models (English)

1 reference

21 September 2017

1 reference

1 reference

Seiji Mabuchi

1 reference

21 September 2017

Masahide Ohmichi

1 reference

21 September 2017

Yukihiro Nishio

1 reference

21 September 2017

Tadashi Hayasaka

1 reference

21 September 2017

Akiko Kimura

1 reference

21 September 2017

Tsuyoshi Ohta

1 reference

21 September 2017

Maki Saito

1 reference

21 September 2017

Jun Kawagoe

1 reference

21 September 2017

Kazuhiro Takahashi

1 reference

21 September 2017

Namiko Yada-Hashimoto

1 reference

21 September 2017

Masahiro Sakata

1 reference

21 September 2017

Teiichi Motoyama

1 reference

21 September 2017

Hirohisa Kurachi

1 reference

21 September 2017

Keiichi Tasaka

1 reference

21 September 2017

Yuji Murata

1 reference

21 September 2017

language of work or name

English

0 references

publication date

16 March 2004

1 reference

Journal of Biological Chemistry

21 September 2017

published in

1 reference

21 September 2017

volume

279

1 reference

21 September 2017

1 reference

21 September 2017

page(s)

23477-23485

1 reference

Inhibition of phosphorylation of BAD and Raf-1 by Akt sensitizes human ovarian cancer cells to paclitaxel

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

Regulation of cell death protease caspase-9 by phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

Transcriptional cross talk between NF-kappaB and p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

NF-kappaB as a therapeutic target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

NF-kappaB is activated and promotes cell death in focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

An essential role for NF-kappaB in preventing TNF-alpha-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

Suppression of TNF-alpha-induced apoptosis by NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

Increase of the resistance of human cervical carcinoma cells to cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NF kappa B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

Inhibition of JNK by cellular stress- and tumor necrosis factor alpha-induced AKT2 through activation of the NF kappa B pathway in human epithelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

The role of constitutive NF-kappaB activity in PC-3 human prostate cancer cell invasive behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

Crystal structure of p50/p65 heterodimer of transcription factor NF-kappaB bound to DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

NF-kappa B: ten years after

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

Role of NF-κB in p53-mediated programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

Regulation of endothelium-derived nitric oxide production by the protein kinase Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

The proteasome--an emerging therapeutic target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

Cancer research. Taking garbage in, tossing cancer out?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313709200

21 January 2018

Identifiers

DOI

10.1074/JBC.M313709200

1 reference

21 September 2017

1 reference